DrugPatentWatch Database Preview
Drugs in Development Information for Bicine
What is the development status for investigational drug Bicine?
Bicine is an investigational drug.
There have been 33 clinical trials for Bicine.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.
The most common disease conditions in clinical trials are Breast Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Gruppo Italiano Malattie EMatologiche dell'Adulto, University of Cologne, and Hellenic Oncology Research Group.
There is one US patent protecting this investigational drug and fifteen international patents.
Summary for Bicine
| US Patents | 1,866 |
| International Patents | 15,945 |
| US Patent Applications | 4,202 |
| WIPO Patent Applications | 1,322 |
| Japanese Patent Applications | 25 |
| Clinical Trial Progress | Phase 3 (2010-05-01) |
| Vendors | 69 |
Recent Clinical Trials for Bicine
| Title | Sponsor | Phase |
|---|---|---|
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | Changzhou No.2 People's Hospital | Phase 3 |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | Huai'an Second People's Hospital | Phase 3 |
| Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients | Jingjiang People's Hospital | Phase 3 |
Clinical Trial Summary for Bicine
Top disease conditions for Bicine
Top clinical trial sponsors for Bicine
US Patents for Bicine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bicine | Start Trial | Double-acylated GLP-1 derivatives | Novo Nordisk A/S (Bagsvaerd, DK) | Start Trial |
| Bicine | Start Trial | Measurement method for human pancreatic lipase activity | ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) | Start Trial |
| Bicine | Start Trial | Dental implant coated with a mixed solution of chemical buffering agent and organic amphiphilic substance and a preparation process thereof | OSSTEMIMPLANT CO., LTD (Seoul, KR) | Start Trial |
| Bicine | Start Trial | Malodor neutralizing composition | Start Trial | |
| Bicine | Start Trial | Trabecular meshwork stem cells | University of Pittsburgh--of the Commonwealth System of Higher Education (Pittsburgh, PA) | Start Trial |
| Bicine | Start Trial | Double-acylated GLP-1 derivatives | Novo Nordisk A/S (Bagsvaerd, DK) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bicine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bicine | China | 104519902 | 2032-05-08 | Start Trial |
| Bicine | European Patent Office | 2846823 | 2032-05-08 | Start Trial |
| Bicine | Japan | 2015517477 | 2032-05-08 | Start Trial |
| Bicine | Japan | 6250034 | 2032-05-08 | Start Trial |
| Bicine | World Intellectual Property Organization (WIPO) | 2013167454 | 2032-05-08 | Start Trial |
| Bicine | China | 105164273 | 2033-04-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
